Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis
Farmeconomia. Health economics and therapeutic pathways
doi 10.7175/fe.v19i1.1385
Full Text
Abstract
Available in
Date
November 30, 2018
Authors
Publisher
Seed SRL